Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VIE

Viela Bio (VIE) Stock Price, News & Analysis

Viela Bio logo

About Viela Bio Stock (NASDAQ:VIE)

Key Stats

Today's Range
$53.01
$53.01
50-Day Range
$52.92
$53.20
52-Week Range
$25.02
$65.00
Volume
N/A
Average Volume
1.07 million shs
Market Capitalization
$2.91 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VIE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viela Bio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VIE Stock News Headlines

RGNX-Aktie erreicht 52-Wochen-Tief bei 9,28 US-Dollar
What The Silver Boom Could Mean For You…
AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-overlooked metal isn’t just about “green tech” anymore — it’s becoming critical to the AI revolution and modern energy systems. A new report explains why silver may be one of the most undervalued assets in the market today, and how everyday investors can use it to diversify and protect their savings. It also outlines a simple IRS-approved strategy that makes owning silver easier than most people realize.tc pixel
Regenxbio Names Mitchell Chan CFO
2024 Fire Awards: Meet this year's Ablaze honorees
See More Headlines

VIE Stock Analysis - Frequently Asked Questions

Viela Bio, Inc. (NASDAQ:VIE) posted its quarterly earnings data on Sunday, February, 28th. The company reported ($0.60) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.70) by $0.10. The company had revenue of $9.34 million for the quarter, compared to the consensus estimate of $5.10 million.

Viela Bio (VIE) raised $150 million in an IPO on Thursday, October 3rd 2019. The company issued 7,500,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, Morgan Stanley and Cowen served as the underwriters for the IPO and Guggenheim Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viela Bio investors own include Enovix (ENVX), Rambus (RMBS), COMPASS Pathways (CMPS), Toast (TOST), Ginkgo Bioworks (DNA), Globant (GLOB) and Saia (SAIA).

Company Calendar

Last Earnings
2/28/2021
Today
9/21/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VIE
CIK
N/A
Fax
N/A
Employees
166
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($7.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$86.43 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-33.97%
Return on Assets
-31.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
19.51
Quick Ratio
19.49

Sales & Book Value

Annual Sales
$50 million
Price / Sales
58.26
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.14 per share
Price / Book
7.42

Miscellaneous

Outstanding Shares
54,950,000
Free Float
N/A
Market Cap
$2.91 billion
Optionable
Not Optionable
Beta
0.43
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:VIE) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners